GO:0060765 regulation of androgen receptor signaling pathway: Mechanism, Genes, Functions and Research Methods
Research-grade guide for scientists and biopharma professionals
Key Takeaways
• GO:0060765 (regulation of androgen receptor signaling pathway) is a biological process that modulates the rate, frequency, or extent of androgen receptor (AR) signaling [1,2].
• AR signaling is driven by androgens such as testosterone and dihydrotestosterone, which bind AR and promote its nuclear translocation and transcriptional activity [2,3].
• Dysregulation of AR signaling is central to prostate cancer progression, including castration-resistant prostate cancer, and also contributes to androgen receptor-positive triple-negative breast cancer [1,2,4].
• Key regulators include coregulators such as FOXA1 and FOXA2, epigenetic modifiers, and DNA repair factors like BRCA1 that influence AR output [5,8].
• In Sertoli cells, AR signaling is essential for normal spermatogenesis, highlighting its role beyond cancer.
• CRISPR-based models (knockout, point mutation, knock-in, overexpression) enable causal dissection of regulators of AR signaling and are supported by EDITGENE services [2,6].
Description
The androgen receptor (AR) signaling pathway is a fundamental biological process that governs gene expression in response to androgens such as testosterone and dihydrotestosterone [2,3]. The Gene Ontology term GO:0060765, regulation of androgen receptor signaling pathway, encompasses any process that modulates the rate, frequency, or extent of this pathway [1,2]. This term is critical for understanding how cells integrate hormonal signals to control proliferation, differentiation, and survival, particularly in prostate and breast tissues [1,2]. Researchers study this process to identify therapeutic targets for hormone-dependent cancers and to understand normal reproductive physiology [6,7]. The pathway is tightly regulated at multiple levels, including ligand availability, receptor post-translational modifications, coregulator recruitment, and epigenetic remodeling [3,8]. Disruption of these regulatory mechanisms can lead to diseases such as prostate cancer and androgen receptor-positive triple-negative breast cancer [1,4]. Consequently, GO:0060765 serves as a hub for both basic and translational research, guiding the development of CRISPR-based models to dissect causal regulators [2,6].
regulation of androgen receptor signaling pathway At A Glance
| GO ID | GO:0060765 |
|---|---|
| GO term | regulation of androgen receptor signaling pathway |
| Ontology | biological_process |
| Synonym | regulation of androgen receptor signalling pathway |
| Major function | Modulates the rate, frequency, or extent of androgen receptor signaling |
| Related diseases | Prostate cancer, androgen receptor-positive triple-negative breast cancer |
| Key regulators | FOXA1, FOXA2, BRCA1, coregulators, epigenetic modifiers |
| Research methods | CRISPR knockout, point mutation, knock-in, overexpression, RNA-seq, ChIP-seq |
What Is GO:0060765?
GO:0060765, regulation of androgen receptor signaling pathway, is defined as any process that modulates the rate, frequency, or extent of the androgen receptor signaling pathway. In other words, it includes all molecular events that either enhance or suppress the cascade triggered by androgen binding to the androgen receptor, from ligand availability and receptor activation to downstream transcriptional outputs [1,2].
Why Is regulation of androgen receptor signaling pathway Important in Cell Biology?
Understanding GO:0060765 is essential because the androgen receptor signaling pathway is a major driver of prostate cancer and contributes to other malignancies such as androgen receptor-positive triple-negative breast cancer [1,2]. Regulatory mechanisms within this process determine therapeutic responses to anti-androgens and influence disease progression to castration-resistant states [4,6]. Moreover, AR signaling is critical for normal male reproductive development and spermatogenesis, as demonstrated in Sertoli cells. Thus, dissecting the regulation of AR signaling provides insights into both physiology and disease, guiding the development of novel therapeutics and CRISPR-based disease models [2,6].
• Central to prostate cancer initiation and progression, including castration-resistant prostate cancer [2,4].
• Contributes to androgen receptor-positive triple-negative breast cancer pathogenesis.
• Essential for normal spermatogenesis and male fertility.
• Determines sensitivity to anti-androgen therapies and resistance mechanisms [4,6].
• Involves epigenetic regulation, such as MMP9 expression via AKT/mTOR signaling.
• Interplays with DNA repair pathways, including BRCA1-mediated antioxidant defense.
• Coregulators like FOXA1 and FOXA2 shape lineage-specific oncogenic output.
• Provides targets for CRISPR-based functional genomics and drug discovery [2,6].
• Serves as a model for studying hormone-dependent transcription and signaling crosstalk.
• Enables development of personalized medicine approaches in oncology [2,6].
What Happens During regulation of androgen receptor signaling pathway?
Ligand Binding and Receptor Activation
In simple terms: Androgens like testosterone bind to the androgen receptor, causing it to change shape and become active.
The regulation of AR signaling begins with the availability of androgens, primarily testosterone and dihydrotestosterone, which bind to the ligand-binding domain of the androgen receptor [2,3]. This binding induces a conformational change that promotes receptor dimerization, phosphorylation, and nuclear translocation. Regulatory processes at this stage include modulation of ligand synthesis by enzymes such as 5-alpha reductase and alterations in AR protein stability [2,6].
Nuclear Translocation and DNA Binding
In simple terms: The activated receptor moves into the nucleus and attaches to specific DNA regions to turn genes on or off.
Upon activation, the androgen receptor translocates to the nucleus, where it binds to androgen response elements (AREs) in the DNA [2,3]. This step is regulated by importins, post-translational modifications, and interactions with chaperones. Coregulators such as FOXA1 can facilitate chromatin accessibility and AR binding to enhancers, thereby modulating transcriptional output.
Transcriptional Coregulation
In simple terms: Helper proteins join the receptor on DNA to fine-tune which genes are activated or repressed.
The androgen receptor recruits a diverse array of coregulators, including coactivators and corepressors, that modify chromatin and interact with the basal transcription machinery [2,3]. For example, FOXA1 and FOXA2 act as pioneer factors that shape the AR cistrome and influence lineage-specific gene expression programs in prostate cancer. Epigenetic modifiers, such as histone acetyltransferases and methyltransferases, also participate in regulating AR-dependent transcription.
Post-Transcriptional and Feedback Regulation
In simple terms: After genes are turned on, the cell uses feedback loops and RNA processing to adjust the response.
Regulation of AR signaling extends beyond transcription to include mRNA splicing, stability, and translation. Negative feedback loops, such as AR-mediated upregulation of its own repressors or microRNAs, help terminate the signal. Additionally, crosstalk with other signaling pathways, such as AKT/mTOR, can modulate AR activity and downstream effects like MMP9 expression.
Interaction with DNA Repair and Antioxidant Pathways
In simple terms: The receptor also communicates with DNA repair and stress-response systems, affecting cell survival.
Recent studies have revealed that AR signaling regulates BRCA1 expression, which in turn modulates antioxidant defense in prostate cancer cells. This interplay between AR and DNA repair pathways influences sensitivity to androgen receptor signaling inhibitors and may contribute to therapeutic resistance [4,5]. Thus, regulation of AR signaling is integrated with genome maintenance and redox homeostasis.
Key Genes Involved in GO:0060765 regulation of androgen receptor signaling pathway
The following genes and proteins are key players in the regulation of androgen receptor signaling, as supported by published literature.
| Gene | Major Role | Research Relevance |
|---|---|---|
| AR | Androgen receptor; mediates androgen signaling | Central to prostate cancer and AR-positive breast cancer [2,3] |
| FOXA1 | Pioneer factor; facilitates AR chromatin binding | Lineage-specific oncogenic output in prostate cancer |
| FOXA2 | Pioneer factor; modulates AR transcriptional program | Disrupts oncogenic program in prostate cancer |
| BRCA1 | DNA repair; regulated by AR; antioxidant defense | Links AR signaling to genome stability |
| MMP9 | Matrix metalloproteinase; regulated by AR via AKT/mTOR | Promotes metastasis in AR-positive TNBC |
| AKT1 | Kinase; modulates AR activity and MMP9 expression | Crosstalk with AR signaling |
| mTOR | Kinase; integrates nutrient and hormonal signals | Regulates AR-dependent MMP9 expression |
| SRC | Coactivator; enhances AR transcriptional activity | Coregulator in prostate cancer |
| NCOA1 | Nuclear receptor coactivator 1; enhances AR function | Coregulator in AR signaling |
| NCOR1 | Nuclear receptor corepressor 1; represses AR activity | Coregulator in AR signaling |
| SP1 | Transcription factor; cooperates with AR | Modulates AR target genes |
| NF-κB | Transcription factor; crosstalk with AR | Inflammatory signaling in prostate cancer |
| PIAS1 | SUMO E3 ligase; modifies AR | Post-translational regulation of AR |
| UBE3A | E3 ubiquitin ligase; targets AR for degradation | Regulates AR stability |
| HSP90 | Chaperone; stabilizes AR in cytoplasm | Required for AR maturation |
| KDM1A | Histone demethylase; modulates AR target genes | Epigenetic regulator in prostate cancer |
| EZH2 | Histone methyltransferase; represses AR target genes | Epigenetic regulator in prostate cancer |
How Is regulation of androgen receptor signaling pathway Regulated?
The regulation of androgen receptor signaling is itself subject to multiple layers of control. Post-translational modifications of AR, including phosphorylation, acetylation, sumoylation, and ubiquitination, modulate its stability, localization, and transcriptional activity. Coregulators such as FOXA1 and FOXA2 can reprogram AR binding and alter downstream gene expression. Additionally, crosstalk with signaling pathways like AKT/mTOR influences AR activity and its effects on target genes such as MMP9. DNA repair factors like BRCA1 are regulated by AR and contribute to antioxidant defense, creating a feedback loop that affects cell survival. These regulatory mechanisms collectively determine the intensity and duration of AR signaling, with implications for cancer therapy [4,6].
regulation of androgen receptor signaling pathway and Human Disease
| Gene | Disease / Biology | Potential Experimental Model |
|---|---|---|
| AR | Prostate cancer, AR-positive TNBC | AR knockout or point-mutant prostate cancer cell lines (e.g., LNCaP) |
| FOXA1 | Prostate cancer progression | FOXA1 knockout or overexpression in prostate cancer cells |
| BRCA1 | Prostate cancer, DNA repair deficiency | BRCA1 knockout in AR-positive prostate cancer cells |
| MMP9 | Metastasis in AR-positive TNBC | MMP9 knockout or overexpression in TNBC cell lines |
| FOXA2 | Prostate cancer lineage plasticity | FOXA2 knockout in prostate cancer organoids |
Prostate Cancer
Dysregulation of androgen receptor signaling is a hallmark of prostate cancer, driving tumor growth and progression [2,3]. Alterations in AR itself, such as mutations or amplification, and changes in coregulators like FOXA1 and FOXA2, contribute to castration-resistant prostate cancer [4,8]. Targeting the regulation of AR signaling is a mainstay of therapy, although resistance often emerges. Recent work highlights the role of DNA repair pathways, including BRCA1, in modulating response to AR signaling inhibitors [4,5].
Androgen Receptor-Positive Triple-Negative Breast Cancer
A subset of triple-negative breast cancers expresses the androgen receptor and depends on AR signaling for proliferation and metastasis. Regulatory mechanisms involving AKT/mTOR and epigenetic control of MMP9 expression promote invasive behavior. Understanding how AR signaling is regulated in this context may reveal new therapeutic opportunities.
Male Reproductive Disorders
In Sertoli cells, androgen receptor signaling is essential for normal spermatogenesis. Disruption of its regulation can lead to impaired fertility and testicular dysfunction. Studying these regulatory mechanisms provides insights into male reproductive health.
From regulation of androgen receptor signaling pathway-Related Genes to Experimental Models
| Research Question | Suitable Model |
|---|---|
| Does loss of a candidate regulator alter AR signaling? | CRISPR knockout cell line (e.g., AR, FOXA1, BRCA1) |
| Does a specific point mutation in AR affect ligand sensitivity? | CRISPR point mutation knock-in (e.g., AR T877A) |
| Does overexpression of a coregulator enhance AR activity? | CRISPR-mediated overexpression (e.g., FOXA1, SRC) |
| Does tagging a protein affect its localization? | Knock-in of fluorescent or epitope tag (e.g., AR-GFP) |
| Does a regulator control AR target gene expression? | CRISPR knockout followed by RNA-seq or ChIP-seq |
| Can we identify novel regulators of AR signaling? | Genome-wide CRISPR library screening |
How to Study the regulation of androgen receptor signaling pathway Process
| Method | What It Measures | Typical Application |
|---|---|---|
| RNA-seq | Global gene expression changes | Identify AR target genes after regulator knockout |
| ChIP-seq | Protein-DNA interactions | Map AR and FOXA1 binding sites |
| Proteomics | Protein abundance and modifications | Assess AR stability and post-translational changes |
| CRISPR screen | Gene function at scale | Discover novel regulators of AR signaling |
| Reporter assay | AR transcriptional activity | Measure effects of candidate regulators |
| qPCR | Specific gene expression | Validate AR target genes like MMP9 |
| Western blot | Protein levels | Confirm AR or coregulator expression |
| Immunofluorescence | Protein localization | Visualize AR nuclear translocation |
Transcriptomic Profiling
RNA sequencing (RNA-seq) is widely used to measure changes in gene expression upon modulation of AR signaling regulators [1,8]. This method can identify AR target genes and pathways affected by CRISPR knockout or overexpression of candidate regulators [2,6].
Chromatin Immunoprecipitation Sequencing
ChIP-seq for AR and histone modifications reveals genome-wide binding sites and chromatin states, helping to define how regulators like FOXA1 and FOXA2 shape the AR cistrome. This approach is essential for understanding transcriptional regulation.
Proteomic and Post-Translational Modification Analysis
Mass spectrometry-based proteomics can quantify AR protein levels, interactions, and post-translational modifications. This is useful for studying how regulators affect AR stability and activity.
Functional Genomic Screens
CRISPR library screens enable unbiased discovery of regulators of AR signaling [2,6]. Coupled with reporter assays or viability readouts, these screens identify genes that modulate AR pathway activity.
How CRISPR Can Be Used to Study GO:0060765 regulation of androgen receptor signaling pathway
Knockout
CRISPR knockout is used to delete candidate regulators of AR signaling, such as FOXA1, BRCA1, or MMP9, to assess their causal role in AR pathway activity and downstream phenotypes [1,5,8]. Knockout cell lines can be subjected to RNA-seq, ChIP-seq, or phenotypic assays to determine the impact on AR signaling [2,6].
Point Mutation
Point mutations in AR or its regulators can be introduced using CRISPR to model clinically relevant alterations, such as AR T877A, which affects ligand specificity [2,3]. These models help dissect how specific amino acid changes influence AR signaling and drug response.
Knock-in
Knock-in of tags or reporters, such as GFP or luciferase, into the AR locus allows real-time monitoring of AR expression and localization. This approach is valuable for studying dynamic regulation of AR signaling in live cells.
Overexpression
CRISPR-mediated overexpression of coregulators like FOXA1 or SRC can be achieved by inserting a strong promoter or using CRISPR activation (CRISPRa). This helps determine whether increased levels of a regulator enhance AR signaling and drive oncogenic phenotypes.
How EDITGENE Supports regulation of androgen receptor signaling pathway Research
Researchers studying regulation of androgen receptor signaling pathway-related genes often need to determine whether a candidate gene is causally involved in AR pathway activity or is merely correlated with it. EDITGENE provides a comprehensive suite of CRISPR-based services to generate precisely engineered cell models, enabling functional validation of regulators of AR signaling.
Contact EDITGENE today to design your custom CRISPR model for regulation of androgen receptor signaling pathway research.
Frequently Asked Questions About regulation of androgen receptor signaling pathway
What is GO:0060765?
GO:0060765 is the Gene Ontology term for regulation of androgen receptor signaling pathway, defined as any process that modulates the rate, frequency, or extent of the androgen receptor signaling pathway [1,2].
What genes are involved in regulation of androgen receptor signaling pathway?
Key genes include AR, FOXA1, FOXA2, BRCA1, MMP9, AKT1, mTOR, and various coregulators such as SRC and NCOA1 [1,3,5,8].
How is androgen receptor signaling regulated?
It is regulated at multiple levels, including ligand availability, receptor post-translational modifications, coregulator recruitment, epigenetic changes, and crosstalk with other pathways like AKT/mTOR [1,3,8].
What diseases are associated with dysregulation of androgen receptor signaling?
Prostate cancer, androgen receptor-positive triple-negative breast cancer, and male reproductive disorders are associated with dysregulation of AR signaling [1,2,7].
What is the role of FOXA1 in androgen receptor signaling?
FOXA1 acts as a pioneer factor that facilitates AR binding to chromatin and shapes lineage-specific transcriptional programs in prostate cancer.
How does BRCA1 regulate androgen receptor signaling?
BRCA1 is regulated by AR and modulates antioxidant defense; its loss affects response to AR signaling inhibitors.
What research methods are used to study regulation of androgen receptor signaling?
Common methods include RNA-seq, ChIP-seq, proteomics, CRISPR screens, reporter assays, and qPCR [1,3,8].
Can CRISPR be used to study androgen receptor signaling?
Yes, CRISPR knockout, point mutation, knock-in, and overexpression models enable causal dissection of regulators of AR signaling [2,6].
What is the link between androgen receptor signaling and triple-negative breast cancer?
A subset of TNBC expresses AR and depends on AR signaling; regulation via AKT/mTOR and MMP9 promotes metastasis.
How does androgen receptor signaling affect spermatogenesis?
In Sertoli cells, AR signaling is essential for normal spermatogenesis, and its disruption impairs fertility.
Conclusion
GO:0060765, regulation of androgen receptor signaling pathway, is a critical biological process that controls hormonal responses in health and disease. Its dysregulation drives prostate cancer and other malignancies, making it a prime target for therapeutic intervention [2,6]. Understanding the complex regulatory layers, from ligand binding to epigenetic and post-translational control, requires robust experimental models [3,8]. CRISPR-based approaches, supported by EDITGENE services, empower researchers to dissect causal regulators and accelerate the development of novel treatments [2,6].
References
- 1. Wu HT et al.. 2021. Luteolin suppresses androgen receptor-positive triple-negative breast cancer cell proliferation and metastasis by epigenetic regulation of MMP9 expression via the AKT/mTOR signaling pathway.. Phytomedicine 81:153437 PMID: 33352494
- 2. Aurilio G et al.. 2020. Androgen Receptor Signaling Pathway in Prostate Cancer: From Genetics to Clinical Applications.. Cells 9(12) PMID: 33321757
- 3. Dehm SM et al.. 2005. Regulation of androgen receptor signaling in prostate cancer.. Expert Rev Anticancer Ther 5(1):63-74 PMID: 15757439
- 4. Zhong C et al.. 2024. GG-NER's role in androgen receptor signaling inhibitor response for advanced prostate cancer.. Cell Commun Signal 22(1):600 PMID: 39696559
- 5. Sriraman S et al.. 2025. Androgen receptor-mediated regulation of BRCA1 modulates the antioxidant defense in prostate cancer.. J Pathol 267(4):385-398 PMID: 41047927
- 6. Obinata D et al.. 2024. Exploring androgen receptor signaling pathway in prostate cancer: A path to new discoveries.. Int J Urol 31(6):590-597 PMID: 38345202
- 7. Wang JM et al.. 2022. What Does Androgen Receptor Signaling Pathway in Sertoli Cells During Normal Spermatogenesis Tell Us?. Front Endocrinol (Lausanne) 13:838858 PMID: 35282467
- 8. Formaggio N et al.. 2025. Targeting FOXA1 and FOXA2 disrupts the lineage-specific oncogenic output program in prostate cancer.. Cell Rep 44(10):116324 PMID: 41014557
